XML 52 R41.htm IDEA: XBRL DOCUMENT
v3.25.2

Segment Information (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Segment Information [Abstract] |
Schedule of Segment Information |
|  | During the Three-Month Period Ended June 30, 2025 |
|  | Scours |  |  | Mastitis |  |  | Other |  |  | Total |
Product sales |  | $ | 6,398,517 |  |  | $ | 46,363 |  |  | $ | — |  |  | $ | 6,444,880 |
Costs of goods sold |  |  | 3,589,893 |  |  |  | 37,063 |  |  |  | — |  |  |  | 3,626,956 |
Gross margin |  |  | 2,808,624 |  |  |  | 9,300 |  |  |  | — |  |  |  | 2,817,924 |
Product development expenses |  |  | 93,011 |  |  |  | 710,745 |  |  |  | 28,102 |  |  |  | 831,858 |
Sales and marketing expenses |  |  | 634,846 |  |  |  | 61,240 |  |  |  | — |  |  |  | 696,086 |
Administrative expenses |  |  | — |  |  |  | — |  |  |  | 720,418 |  |  |  | 720,418 |
Operating expenses |  |  | 727,857 |  |  |  | 771,985 |  |  |  | 748,520 |  |  |  | 2,248,362 |
NET OPERATING INCOME (LOSS) |  | $ | 2,080,767 |  |  | $ | (762,685 | ) |  | $ | (748,520 | ) |  | $ | 569,562 |
|  | During the Three-Month Period Ended June 30, 2024 |
|  | Scours |  |  | Mastitis |  |  | Other |  |  | Total |
Product sales |  | $ | 5,430,069 |  |  | $ | 42,821 |  |  | $ | — |  |  | $ | 5,472,890 |
Costs of goods sold |  |  | 4,198,849 |  |  |  | 43,555 |  |  |  | — |  |  |  | 4,242,404 |
Gross margin |  |  | 1,231,220 |  |  |  | (734 | ) |  |  | — |  |  |  | 1,230,486 |
Product development expenses |  |  | 65,598 |  |  |  | 928,531 |  |  |  | 36,373 |  |  |  | 1,030,502 |
Sales and marketing expenses |  |  | 855,513 |  |  |  | 129,444 |  |  |  | — |  |  |  | 984,957 |
Administrative expenses |  |  | — |  |  |  | — |  |  |  | 601,634 |  |  |  | 601,634 |
Operating expenses |  |  | 921,111 |  |  |  | 1,057,975 |  |  |  | 638,007 |  |  |  | 2,617,093 |
NET OPERATING INCOME (LOSS) |  | $ | 310,109 |  |  | $ | (1,058,709 | ) |  | $ | (638,007 | ) |  | $ | (1,386,607 | )
|  | Scours |  |  | Mastitis |  |  | Other |  |  | Total |
Total Assets as of June 30, 2025 |  | $ | 24,612,357 |  |  | $ | 15,924,755 |  |  | $ | 6,183,786 |  |  | $ | 46,720,898 |
Total Assets as of June 30, 2024 |  | $ | 23,240,545 |  |  | $ | 17,107,377 |  |  | $ | 1,507,536 |  |  | $ | 41,855,458 |
Depreciation and amortization expense during the three-month period ended June 30, 2025 |  | $ | 345,512 |  |  | $ | 314,175 |  |  | $ | 19,350 |  |  | $ | 679,037 |
Depreciation and amortization expense during the three-month period ended June 30, 2024 |  | $ | 342,362 |  |  | $ | 319,727 |  |  | $ | 19,676 |  |  | $ | 681,765 |
Capital Expenditures during the three-month period ended June 30, 2025 |  | $ | 151,808 |  |  | $ | 1,079 |  |  | $ | 2,271 |  |  | $ | 155,158 |
Capital Expenditures during the three month period ended June 30, 2024 |  | $ | 93,338 |  |  | $ | 17,403 |  |  | $ | — |  |  | $ | 110,741 |
|  | During the Six-Month Period Ended June 30, 2025 |
|  | Scours |  |  | Mastitis |  |  | Other |  |  | Total |
Product sales |  | $ | 14,427,003 |  |  | $ | 85,051 |  |  | $ | — |  |  | $ | 14,512,054 |
Costs of goods sold |  |  | 8,264,436 |  |  |  | 75,722 |  |  |  | — |  |  |  | 8,340,158 |
Gross margin |  |  | 6,162,567 |  |  |  | 9,329 |  |  |  | — |  |  |  | 6,171,896 |
Product development expenses |  |  | 186,496 |  |  |  | 1,339,657 |  |  |  | 62,552 |  |  |  | 1,588,705 |
Sales and marketing expenses |  |  | 1,421,983 |  |  |  | 130,761 |  |  |  | — |  |  |  | 1,552,744 |
Administrative expenses |  |  | — |  |  |  | — |  |  |  | 1,343,260 |  |  |  | 1,343,260 |
Operating expenses |  |  | 1,608,479 |  |  |  | 1,470,418 |  |  |  | 1,405,812 |  |  |  | 4,484,709 |
NET OPERATING INCOME (LOSS) |  | $ | 4,554,088 |  |  | $ | (1,461,089 | ) |  | $ | (1,405,812 | ) |  | $ | 1,687,187 |
|  | During the Six-Month Period Ended June 30, 2024 |
|  | Scours |  |  | Mastitis |  |  | Other |  |  | Total |
Product sales |  | $ | 12,650,710 |  |  | $ | 79,757 |  |  | $ | — |  |  | $ | 12,730,467 |
Costs of goods sold |  |  | 9,122,397 |  |  |  | 82,225 |  |  |  | — |  |  |  | 9,204,622 |
Gross margin |  |  | 3,528,313 |  |  |  | (2,468 | ) |  |  | — |  |  |  | 3,525,845 |
Product development expenses |  |  | 95,093 |  |  |  | 2,131,473 |  |  |  | 66,487 |  |  |  | 2,293,053 |
Sales and marketing expenses |  |  | 1,525,252 |  |  |  | 260,628 |  |  |  | — |  |  |  | 1,785,880 |
Administrative expenses |  |  | — |  |  |  | — |  |  |  | 1,133,572 |  |  |  | 1,133,572 |
Operating expenses |  |  | 1,620,345 |  |  |  | 2,392,101 |  |  |  | 1,200,059 |  |  |  | 5,212,505 |
NET OPERATING INCOME (LOSS) |  | $ | 1,907,968 |  |  | $ | (2,394,569 | ) |  | $ | (1,200,059 | ) |  | $ | (1,686,660 | )
|  | Scours |  |  | Mastitis |  |  | Other |  |  | Total |
Total Assets as of June 30, 2025 |  | $ | 24,612,357 |  |  | $ | 15,924,755 |  |  | $ | 6,183,786 |  |  | $ | 46,720,898 |
Total Assets as of June 30, 2024 |  | $ | 23,240,545 |  |  | $ | 17,107,377 |  |  | $ | 1,507,536 |  |  | $ | 41,855,458 |
Depreciation and amortization expense during the six-month period ended June 30, 2025 |  | $ | 698,034 |  |  | $ | 628,834 |  |  | $ | 38,942 |  |  | $ | 1,365,810 |
Depreciation and amortization expense during the six-month period ended June 30, 2024 |  | $ | 681,281 |  |  | $ | 638,445 |  |  | $ | 39,539 |  |  | $ | 1,359,265 |
Capital Expenditures during the six-month period ended June 30, 2025 |  | $ | 474,185 |  |  | $ | 7,752 |  |  | $ | 2,271 |  |  | $ | 484,208 |
Capital Expenditures during the six-month period ended June 30, 2024 |  | $ | 132,812 |  |  | $ | 48,285 |  |  | $ | — |  |  | $ | 181,097 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration